Whole-body MRI radiology group Prenuvo hires former Peloton CFO

Prenuvo has hired Peloton’s former CFO, who will help lead the whole-body MRI group’s financial strategy as it enters the “next phase of growth.” 

Jill Woodworth previously served as chief financial officer of the fitness company from 2018 to 2022, leading Peloton from pre-IPO to a phenomenon notching $4 billion-plus in revenue. She’ll now hold the same title with Redwood City, California-based Prenuvo, overseeing its fiscal strategy, operations and long-term planning. 

“Jill brings a rare combination of financial acumen and a deep understanding of consumer-driven health,” Andrew Lacy, MBA, founder and CEO of Prenuvo, said in a May 15 announcement. “She’s helped build one of the most recognized brands of the last decade, and her leadership will be essential as we scale globally and continue making proactive health more accessible.”

While at Peloton, Woodworth played a “critical role” in preparing the company for an initial public offering, also navigating pandemic demand surges and "building operational infrastructure to support massive consumer adoption,” Prenuvo noted. Most recently, she was CFO at data intelligence platform Alation, and before Peloton, she was managing director with J.P. Morgan for 12 years. 

The hire comes as Prenuvo is seeing “record” interest in its elective whole-body MRI, which charges consumers $2,499 to root out cancer and other concerns before they become symptomatic. Lacy and colleagues said they have now delivered over 130,000 of the exams, also recently launching an “enhanced” version that costs $3,999, incorporating lab testing and a body-composition analysis. The new offering accounts for about 25% of business at locations where it’s offered, including outposts in New York (where it costs $4,499), Redwood City, Calif., Los Angeles, Boca Raton, Fla., Bethesda, Md., and Dallas. 

Prenuvo plans to launch 15 more locations in the near-term, among them, the first sites in Australia and Europe. The company bills itself as the “world’s largest private radiology team dedicated entirely to proactive whole body MRI screening,” employing over 100 board-certified radiologists. Prenuvo has scored endorsements from celebrities such as Kim Kardashian and Paris Hilton, with super model Cindy Crawford an investor. 

“What drew me to Prenuvo is the same thing that drew me to Peloton years ago: the opportunity to change lives at scale,” Woodworth said in the announcement. “After experiencing a scan myself, I realized how powerful it is to truly see what’s happening inside your body. The more I learned, the clearer it became that no one else in this space is approaching this like Prenuvo. I believe Prenuvo and proactive healthcare can become as ubiquitous and essential as fitness and wellness movements have become in the past decade.” 

Others have joined the crowded whole-body MRI space, including startup Ezra (recently acquired by another celebrity-backed company called Function Health) and radiology practice SimonMed Imaging. Prenuvo has drawn criticism for its high cost and lack of long-term data to support the care model. The American College of Radiology does not endorse elective whole-body imaging, noting there are no scientific studies proving they prolong life. Radiologists also have expressed concern these MRIs may lead to a cascade of additional unnecessary healthcare services to investigate insignificant findings. 

Woodworth announced she was stepping down as CFO of Peloton in June 2022, replaced by Amazon veteran Elizabeth Coddington, MBA. Her departure came after Peloton had struggled to maintain the growth it achieved at the height of the pandemic, with the company also facing pressure from an activist investor to pursue a possible sale.